Valued at USD 3.13 billion in 2024, the gout therapeutics market is projected to reach USD 3.34 billion in 2025 and USD 6.15 billion by 2034, growing at a CAGR of 7.0% during the forecast period 2025–2034, according to Polaris Market Research. Gout is a form of inflammatory arthritis caused by uric acid crystal deposition. The gout therapeutics market comprises pharmaceutical...